Investigator initiate study to compare 0.2 mg vs 0.3 mg GnRH agonist trigger in ART
Not Applicable
Suspended
- Conditions
- Health Condition 1: O090- Supervision of pregnancy with history of infertility
- Registration Number
- CTRI/2022/08/044606
- Lead Sponsor
- Indira IVF Hospital Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Antral follicle count on day 2 of menses <5
2) AMH < 1.2 ng /dl
Exclusion Criteria
1) BMI; = 30 kg/m2
2) Presence of endocrine disorders; (uncontrolled diabetes mellitus, / hyperprolactinemia, thyroid dysfunction,
3) Congenital adrenal hyperplasia, Cushing syndrome, or polycystic ovary syndrome
4)Previous major uterine surgery
5)Donor oocyte cycle.
6) Gestational carrier
7) Fertility preservation.
8) Adenomyosis
9) Endometriosis
10) Premature ovarian failure.
11) Thin endometrium <6mm after 21 days of HRT (oestradiol valerate).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of mature oocytes retrievalTimepoint: on the day of ovum of Pick up
- Secondary Outcome Measures
Name Time Method Clinical pregnancy rateTimepoint: 4-6 weeks after embryo transfer;Follicle oocyte indexTimepoint: On the day of ovum pick-up <br/ ><br>10- 15 days of start of simulation;Implantation rateTimepoint: 4- 6 weeks after embryo transfer;OHSS occurrence rateTimepoint: 4 weeks from ovum pick up;Ongoing pregnancy rateTimepoint: 12th week of gestation;Oocyte retrieval rateTimepoint: On the day of ovum pick-up <br/ ><br>10- 15 days of start of simulation